Breaking News Instant updates and real-time market news.

COLD

Americold Realty Trust

$38.46 /

-0.13 (-0.34%)

15:17
05/06/21
05/06
15:17
05/06/21
15:17

Americold Realty Trust trading halted, news pending

  • 06

    May

  • 14

    Oct

COLD Americold Realty Trust
$38.46 /

-0.13 (-0.34%)

10/14/20 Truist
Agro deal gives Americold more scale, platform in Europe, says Truist
08/24/20 Truist
Truist raises price targets on select REITs
08/13/20 Berenberg
Americold Realty Trust upgraded to Buy from Hold at Berenberg
05/11/20 BofA
Americold Realty Trust upgraded to Buy from Neutral at BofA

TODAY'S FREE FLY STORIES

Hot Stocks
GSK, Vir Biotechnology expect initial data from COMET-PEAK study in 2H21 » 07:12
06/21/21
06/21
07:12
06/21/21
07:12
GSK

GlaxoSmithKline

$39.84 /

-0.72 (-1.78%)

, VIR

Vir Biotechnology

$46.11 /

+2.24 (+5.11%)

The companies are pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

  • 08
    Jul
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

Initiation
East West Bancorp assumed with a Buy at Truist » 07:11
06/21/21
06/21
07:11
06/21/21
07:11
EWBC

East West Bancorp

$66.24 /

-2.29 (-3.34%)

Truist analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EWBC East West Bancorp
$66.24 /

-2.29 (-3.34%)

05/18/21 Compass Point
East West Bancorp price target raised to $82 from $75 at Compass Point
03/30/21 DA Davidson
East West Bancorp upgraded to Buy from Neutral at DA Davidson
03/30/21 DA Davidson
East West Bancorp upgraded to Buy from Neutral at DA Davidson
03/18/21 Morgan Stanley
East West Bancorp price target raised to $85 from $79 at Morgan Stanley
EWBC East West Bancorp
$66.24 /

-2.29 (-3.34%)

Hot Stocks
GSK, Vir Biotechnology report results from Phase 3 study of sotrovimab » 07:11
06/21/21
06/21
07:11
06/21/21
07:11
GSK

GlaxoSmithKline

$39.84 /

-0.72 (-1.78%)

, VIR

Vir Biotechnology

$46.11 /

+2.24 (+5.11%)

GlaxoSmithKline (GSK) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

  • 08
    Jul
GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

GSK GlaxoSmithKline
$39.84 /

-0.72 (-1.78%)

Downgrade
Orphazyme downgraded to Sell from Neutral at Guggenheim » 07:10
06/21/21
06/21
07:10
06/21/21
07:10
ORPH

Orphazyme

$7.31 /

-7.24 (-49.76%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

06/18/21 Cowen
Orphazyme downgraded to Market Perform from Outperform at Cowen
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
  • 29
    Sep
ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

Hot Stocks
Valens Company completes acquisition of Green Roads for total of $40M » 07:09
06/21/21
06/21
07:09
06/21/21
07:09
VLNCF

Valens Company

$2.53 /

-0.13937 (-5.22%)

The Valens Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLNCF Valens Company
$2.53 /

-0.13937 (-5.22%)

VLNCF Valens Company
$2.53 /

-0.13937 (-5.22%)

04/15/21 Raymond James
Valens Company upgraded to Market Perform from Underperform at Raymond James
02/26/21 Stifel
Valens Company price target raised to C$3.75 from C$3.35 at Stifel
02/26/21 Canaccord
Valens Company price target lowered to C$3.50 from C$4.50 at Canaccord
02/01/21 Canaccord
Valens Company price target lowered to C$4.50 from C$6 at Canaccord
VLNCF Valens Company
$2.53 /

-0.13937 (-5.22%)

Initiation
PacWest Bancorp assumed with a Hold at Truist » 07:09
06/21/21
06/21
07:09
06/21/21
07:09
PACW

PacWest Bancorp

$40.33 /

-0.8 (-1.95%)

Truist analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACW PacWest Bancorp
$40.33 /

-0.8 (-1.95%)

PACW PacWest Bancorp
$40.33 /

-0.8 (-1.95%)

06/01/21 Raymond James
PacWest Bancorp price target raised to $55 from $48 at Raymond James
04/27/21 Truist
PacWest Bancorp price target raised to $45 from $34 at Truist
04/22/21 Raymond James
PacWest Bancorp upgraded to Strong Buy from Outperform at Raymond James
04/22/21 RBC Capital
PacWest Bancorp price target raised to $50 from $43 at RBC Capital
PACW PacWest Bancorp
$40.33 /

-0.8 (-1.95%)

Hot Stocks
Taysha Gene publishes new analysis of of natural history data for TSHA-120 » 07:09
06/21/21
06/21
07:09
06/21/21
07:09
TSHA

Taysha Gene Therapies

$25.86 /

+0.84 (+3.36%)

Taysha Gene Therapies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$25.86 /

+0.84 (+3.36%)

TSHA Taysha Gene Therapies
$25.86 /

+0.84 (+3.36%)

06/14/21 BTIG
Taysha Gene Therapies initiated with a Buy at BTIG
06/09/21 Wedbush
Taysha Gene Therapies initiated with an Outperform at Wedbush
06/08/21 JMP Securities
Taysha Gene Therapies initiated with an Outperform at JMP Securities
05/19/21
Fly Intel: Top five analyst initiations
TSHA Taysha Gene Therapies
$25.86 /

+0.84 (+3.36%)

  • 24
    Sep
Hot Stocks
Tonix Pharmaceuticals announces program to develop TNX-102 SL for PASC » 07:07
06/21/21
06/21
07:07
06/21/21
07:07
TNXP

Tonix Pharmaceuticals

$1.21 /

-0.015 (-1.23%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$1.21 /

-0.015 (-1.23%)

TNXP Tonix Pharmaceuticals
$1.21 /

-0.015 (-1.23%)

02/25/21 Alliance Global Partners
Tonix price target raised to $4 from $3 at Alliance Global Partners
12/21/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Aptinyx after competitor fails in PTSD
08/20/20 Alliance Global Partners
Tonix price target raised to $3 from $2.50 at Alliance Global Partners
TNXP Tonix Pharmaceuticals
$1.21 /

-0.015 (-1.23%)

TNXP Tonix Pharmaceuticals
$1.21 /

-0.015 (-1.23%)

Hot Stocks
RedHill Biopharma announces presentation of oral opaganib phase 2 data » 07:07
06/21/21
06/21
07:07
06/21/21
07:07
RDHL

RedHill Biopharma

$6.96 /

-0.04 (-0.57%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$6.96 /

-0.04 (-0.57%)

RDHL RedHill Biopharma
$6.96 /

-0.04 (-0.57%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 WBB Securities
RedHill Biopharma downgraded to Buy at WBB Securities as Aemcolo sales slow
05/28/21 WBB Securities
RedHill Biopharma downgraded to Buy from Strong Buy at WBB Securities
05/18/21 H.C. Wainwright
RedHill Biopharma initiated with a Buy at H.C. Wainwright
RDHL RedHill Biopharma
$6.96 /

-0.04 (-0.57%)

  • 02
    Mar
RDHL RedHill Biopharma
$6.96 /

-0.04 (-0.57%)

Initiation
Flywire initiated with an Outperform at Raymond James » 07:06
06/21/21
06/21
07:06
06/21/21
07:06
FLYW

Flywire

$33.80 /

+1.45 (+4.48%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLYW Flywire
$33.80 /

+1.45 (+4.48%)

FLYW Flywire
$33.80 /

+1.45 (+4.48%)

07:00 Today William Blair
William Blair starts Flywire at Outperform on 'growth mode'
06:34 Today Wolfe Research
Flywire initiated with an Outperform at Wolfe Research
06:32 Today Guggenheim
Flywire initiated with a Buy at Guggenheim
06:15 Today Citi
Flywire initiated with a Buy at Citi
  • 26
    May
FLYW Flywire
$33.80 /

+1.45 (+4.48%)

Hot Stocks
Enochian acquires exclusive license for potential coronavirus technology » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
ENOB

Enochian Biosciences

$5.78 /

-0.13 (-2.20%)

Enochian BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENOB Enochian Biosciences
$5.78 /

-0.13 (-2.20%)

ENOB Enochian Biosciences
$5.78 /

-0.13 (-2.20%)

Initiation
AES Corp. initiated with a Positive at Susquehanna » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
AES

AES Corp.

$25.14 /

-0.93 (-3.57%)

Susquehanna analyst Biju…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AES AES Corp.
$25.14 /

-0.93 (-3.57%)

AES AES Corp.
$25.14 /

-0.93 (-3.57%)

01/11/21 BofA
BofA US 1 List changes
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
08/13/20 BofA
AES Corp. added to US 1 List; Ameren removed at BofA
AES AES Corp.
$25.14 /

-0.93 (-3.57%)

AES AES Corp.
$25.14 /

-0.93 (-3.57%)

Hot Stocks
Torchlight Energy Resources, Metamaterial extend closing date for combination » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
TRCH

Torchlight Energy Resources

$6.26 /

+0.875 (+16.25%)

Torchlight Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRCH Torchlight Energy Resources
$6.26 /

+0.875 (+16.25%)

  • 08
    Feb
TRCH Torchlight Energy Resources
$6.26 /

+0.875 (+16.25%)

TRCH Torchlight Energy Resources
$6.26 /

+0.875 (+16.25%)

TRCH Torchlight Energy Resources
$6.26 /

+0.875 (+16.25%)

Hot Stocks
Allogene Overland Biopharm appoints Shuyuan Yao as CEO » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
ALLO

Allogene Therapeutics

$24.47 /

-0.21 (-0.85%)

Allogene Overland…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$24.47 /

-0.21 (-0.85%)

ALLO Allogene Therapeutics
$24.47 /

-0.21 (-0.85%)

05/20/21 Jefferies
Allogene update exceeds expectation 'on all fronts,' says Jefferies
05/20/21 Stifel
Allogene data 'better than they appear on the surface,' says Stifel
05/20/21 Truist
Allogene Therapeutics upgraded to Buy from Hold at Truist
05/20/21 Truist
Allogene Therapeutics upgraded to Buy from Hold at Truist
ALLO Allogene Therapeutics
$24.47 /

-0.21 (-0.85%)

ALLO Allogene Therapeutics
$24.47 /

-0.21 (-0.85%)

Hot Stocks
ZIM Integrated, Alibaba.com announce extension of agreement until 2023 » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
ZIM

ZIM Integrated

$42.34 /

-0.64 (-1.49%)

, BABA

Alibaba

$212.00 /

+0.365 (+0.17%)

ZIM Integrated Shipping…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZIM ZIM Integrated
$42.34 /

-0.64 (-1.49%)

BABA Alibaba
$212.00 /

+0.365 (+0.17%)

ZIM ZIM Integrated
$42.34 /

-0.64 (-1.49%)

06/16/21 Citi
ZIM Integrated resumed with a Buy at Citi
06/10/21 Jefferies
ZIM Integrated price target raised to $60 from $55 at Jefferies
03/23/21 Jefferies
ZIM Integrated price target raised to $35 from $30 at Jefferies
03/22/21 Clarksons Platou
ZIM Integrated price target raised to $38 from $30 at Clarksons Platou
BABA Alibaba
$212.00 /

+0.365 (+0.17%)

05/17/21 Susquehanna
Alibaba opportunity ahead despite regulatory concerns, says Susquehanna
05/14/21 Truist
Alibaba price target lowered to $290 from $315 at Truist
05/14/21 Benchmark
Alibaba price target lowered to $285 from $310 at Benchmark
05/14/21 Baird
Alibaba price target lowered to $270 from $285 at Baird
ZIM ZIM Integrated
$42.34 /

-0.64 (-1.49%)

BABA Alibaba
$212.00 /

+0.365 (+0.17%)

  • 04
    Jun
  • 28
    Jan
BABA Alibaba
$212.00 /

+0.365 (+0.17%)

ZIM ZIM Integrated
$42.34 /

-0.64 (-1.49%)

BABA Alibaba
$212.00 /

+0.365 (+0.17%)

ZIM ZIM Integrated
$42.34 /

-0.64 (-1.49%)

BABA Alibaba
$212.00 /

+0.365 (+0.17%)

General news
European stock markets are broadly higher. » 07:05
06/21/21
06/21
07:05
06/21/21
07:05
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Initiation
American Battery Metals initiated with a Buy at Alliance Global Partners » 07:04
06/21/21
06/21
07:04
06/21/21
07:04
ABML

American Battery Metals

$2.21 /

-0.07 (-3.07%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABML American Battery Metals
$2.21 /

-0.07 (-3.07%)

Hot Stocks
Oyster Point Pharma enrolls first subject in OLYMPIA Phase 2 trial » 07:04
06/21/21
06/21
07:04
06/21/21
07:04
OYST

Oyster Point Pharma

$20.16 /

+0.95 (+4.95%)

Oyster Point Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OYST Oyster Point Pharma
$20.16 /

+0.95 (+4.95%)

OYST Oyster Point Pharma
$20.16 /

+0.95 (+4.95%)

04/23/21 Piper Sandler
Oyster Point has 'most compelling 'dry eye data to date, says Piper Sandler
08/05/20 Piper Sandler
Oyster Point Pharma remains 'fundamentally undervalued,' says Piper Sandler
OYST Oyster Point Pharma
$20.16 /

+0.95 (+4.95%)

Hot Stocks
Ingersoll-Rand to acquire Seepex for EUR 431.5M in all-cash transaction » 07:03
06/21/21
06/21
07:03
06/21/21
07:03
IR

Ingersoll-Rand

$45.49 /

-0.49 (-1.07%)

Ingersoll Rand has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$45.49 /

-0.49 (-1.07%)

IR Ingersoll-Rand
$45.49 /

-0.49 (-1.07%)

06/17/21 Vertical Research
Ingersoll-Rand upgraded to Buy from Hold at Vertical Research
06/17/21 Vertical Research
Ingersoll-Rand upgraded to Buy from Hold at Vertical Research
06/14/21 Credit Suisse
Ingersoll-Rand reinstated with a Neutral at Credit Suisse
05/19/21 Deutsche Bank
Deutsche Bank upgrades 'laggard' Ingersoll-Rand to Buy
IR Ingersoll-Rand
$45.49 /

-0.49 (-1.07%)

  • 11
    May
IR Ingersoll-Rand
$45.49 /

-0.49 (-1.07%)

IR Ingersoll-Rand
$45.49 /

-0.49 (-1.07%)

Hot Stocks
Condor Hospitality Trust evaluates strategic alternatives » 07:03
06/21/21
06/21
07:03
06/21/21
07:03
CDOR

Condor Hospitality Trust

$4.60 /

-0.26 (-5.35%)

Condor Hospitality…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDOR Condor Hospitality Trust
$4.60 /

-0.26 (-5.35%)

CDOR Condor Hospitality Trust
$4.60 /

-0.26 (-5.35%)

10/21/20 B. Riley Securities
Condor Hospitality price target lowered to $4 from $5 at B. Riley Securities
CDOR Condor Hospitality Trust
$4.60 /

-0.26 (-5.35%)

Hot Stocks
Agios Pharmaceuticals submits NDA for mitapivat for PK deficiency » 07:03
06/21/21
06/21
07:03
06/21/21
07:03
AGIO

Agios Pharmaceuticals

$60.44 /

+0.775 (+1.30%)

Agios Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$60.44 /

+0.775 (+1.30%)

AGIO Agios Pharmaceuticals
$60.44 /

+0.775 (+1.30%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
AGIO Agios Pharmaceuticals
$60.44 /

+0.775 (+1.30%)

Hot Stocks
Sierra Oncology announces completion of enrollment for MOMENTUM phase 3 trial » 07:02
06/21/21
06/21
07:02
06/21/21
07:02
SRRA

Sierra Oncology

$18.00 /

-0.4 (-2.17%)

Sierra Oncology announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRRA Sierra Oncology
$18.00 /

-0.4 (-2.17%)

12/11/20 H.C. Wainwright
Sierra Oncology assumed with a Buy at H.C. Wainwright
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 H.C. Wainwright
Sierra Oncology initiated with a Buy at H.C. Wainwright
SRRA Sierra Oncology
$18.00 /

-0.4 (-2.17%)

Downgrade
CAI International downgraded to Market Perform from Outperform at William Blair » 07:02
06/21/21
06/21
07:02
06/21/21
07:02
CAI

CAI International

$56.03 /

+17.84 (+46.71%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAI CAI International
$56.03 /

+17.84 (+46.71%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

06/18/21 B. Riley
CAI International downgraded to Neutral from Buy at B. Riley
06/09/21 B. Riley
CAI International transferred with Buy at B. Riley
03/26/21 B. Riley Securities
CAI International price target raised to $60 from $50 at B. Riley Securities
02/17/21 B. Riley Securities
CAI International price target raised to $50 from $44 at B. Riley Securities
CAI CAI International
$56.03 /

+17.84 (+46.71%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

Initiation
ZipRecruiter initiated with a Strong Buy at Raymond James » 07:02
06/21/21
06/21
07:02
06/21/21
07:02
ZIP

ZipRecruiter

$21.26 /

+0.56 (+2.71%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZIP ZipRecruiter
$21.26 /

+0.56 (+2.71%)

06:58 Today William Blair
ZipRecruiter initiated with an Outperform at William Blair
06:16 Today Evercore ISI
ZipRecruiter initiated with an Outperform at Evercore ISI
06/20/21 Goldman Sachs
ZipRecruiter initiated with a Buy at Goldman Sachs
  • 26
    May
ZIP ZipRecruiter
$21.26 /

+0.56 (+2.71%)

Hot Stocks
Day One receives orphan designation from European Commission for DAY101 » 07:02
06/21/21
06/21
07:02
06/21/21
07:02
DAWN

Day One Biopharmaceuticals

$21.42 /

+2.1899 (+11.39%)

Day One…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

06:18 Today Wedbush
Day One Biopharmaceuticals initiated with an Outperform at Wedbush
06:14 Today Cowen
Day One Biopharmaceuticals initiated with an Outperform at Cowen
04:57 Today Piper Sandler
Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
  • 27
    May
DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.